Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Recce Pharmaceuticals Ltd. announced a change in the interests of Director Dr. John Prendergast, who acquired 2,650,000 unlisted options under the company’s Employee Incentive Plan. These options have an estimated value of $0.244 each, calculated using the Black Scholes valuation method, highlighting the director’s increased stake in the company.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
